Reid Laurence

Reid Laurence is listed in filings as Director at Metagenomi, Inc. Common Stock. This profile follows SEC Form 4 activity through Sep 2, 2025, including 2 public disclosures. Recent filings connect the profile to Metagenomi, Inc. Common Stock (MGX) and KalVista Pharmaceuticals, Inc. (KALV). The current snapshot covers public activity from Nov 26, 2024 to Sep 2, 2025. Reported amounts are shown as $76.4K to $171.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.